
Ancillary study of Vitamin D and Omega-3 Trial finds vitamin D supplementation does not have significant impact on fracture risk
Results showed that vitamin D supplementation did not have a significant impact on fracture risk. Industry advocates are criticizing the study's protocol.
In an
Commenting on the results of the ancillary study, Andrea Wong, PhD, the Council for Responsible Nutrition’s (CRN; Washington, D.C.) senior vice president of scientific and regulatory affairs stated that vitamin D needs to work in tandem with calcium to be effectively support bone health and strength. This is because calcium, “helps build and maintain bones, while vitamin D helps your body effectively absorb calcium,” says Wong. Additionally, Wong points out, the study did not recruit subjects on the basis of vitamin D deficiency, low bone mass, or osteoporosis. Therefore, the results were based on a population that is generally healthy, and would not necessarily derive a substantial benefit from vitamin D when it comes to fracture risk.
“Despite the limitations of the ancillary study, the main VITAL findings and another ancillary study have added to the body of research on vitamin D’s impact on health, including promising results for reducing the risk of cancer-related death and autoimmune diseases. These and other important benefits have been completely ignored in the accompanying
Reference
- LeBoff MS et al. “Supplemental vitamin D and incident fractures in midlife and older adults.” The New England Journal of Medicine, vol. 387 (2022): 299-309
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





